$0.20 -0.01 (-4.85%)
Abpro Holdings, Inc Common Stock (ABP)
Abpro Holdings, Inc. (ABP) is a biotechnology company focused on developing immuno-oncology and ophthalmology therapies. It specializes in creating innovative treatments using antibody-based approaches to address unmet medical needs in cancer and eye diseases. The company leverages its proprietary platform to discover and advance novel biologics.
Company News
Sitryx appoints Adam Mostafa as Chief Financial Officer
Sitryx Therapeutics has appointed Adam Mostafa as its new Chief Financial Officer, bringing over 25 years of biotech financial experience, including previous roles at X4 Pharmaceuticals and Abpro Holdings.